Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma
Clinical trial NCT00664144 · TERMINATED
Trial details
- NCT number
- NCT00664144
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2005-01-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.